V
Vividion Therapeutics
Expanding the therapeutic potential of small molecules
About Vividion Therapeutics
Vividion Therapeutics is a biopharmaceutical company that operates as a wholly owned and independently operated subsidiary of Bayer AG. The company focuses on the development of small-molecule therapeutics for oncology and immunology indications. Its proprietary chemoproteomic platform technology allows for the identification of previously unknown, or "undruggable," protein targets, enabling the discovery of novel drugs.
Read full description
The company's business model is centered on research and development, with a pipeline of candidates in various stages of preclinical and clinical development. Vividion collaborates with its parent company, Bayer, to advance its programs, benefiting from the larger company's resources and expertise while maintaining its operational independence. The company's revenue is primarily generated through milestone payments and royalties from its collaboration and licensing agreements.
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
Cardinal Partners
ARCH Venture Partners
Versant Ventures
Nextech Invest
Casdin Capital
Altitude Life Science Ventures- TCTrinitas Capital
Series B and later16 investors entered at this stage
Bristol-Myers Squibb
Celgene
Tavistock Group
Logos Capital
Driehaus Capital Management- APAcuta Capital Partners
T. Rowe Price
Avoro Capital Advisors
Mubadala Capital
BVF Partners
Citadel
RA Capital Management
Boxer Capital
BlackRock
SoftBank
Woodline Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
17 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vividion Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vividion Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.